Previous Article | Next Article 
Journal of Virology, June 2004, p. 5891-5899, Vol. 78, No. 11
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.11.5891-5899.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Antisense Morpholino-Oligomers Directed against the 5' End of the Genome Inhibit Coronavirus Proliferation and Growth
Benjamin W. Neuman,1* David A. Stein,2 Andrew D. Kroeker,2 Amy D. Paulino,1 Hong M. Moulton,2 Patrick L. Iversen,2 and Michael J. Buchmeier1
The Scripps Research Institute, Department of Neuropharmacology, Division of Virology, La Jolla, California 92037,1
AVI BioPharma, Corvallis, Oregon 973332
Received 17 September 2003/
Accepted 27 January 2004
Conjugation of a peptide related to the human immunodeficiency virus type 1 Tat represents a novel method for delivery of antisense morpholino-oligomers. Conjugated and unconjugated oligomers were tested to determine sequence-specific antiviral efficacy against a member of the Coronaviridae, Mouse hepatitis virus (MHV). Specific antisense activity designed to block translation of the viral replicase polyprotein was first confirmed by reduction of luciferase expression from a target sequence-containing reporter construct in both cell-free and transfected cell culture assays. Peptide-conjugated morpholino-oligomers exhibited low toxicity in DBT astrocytoma cells used for culturing MHV. Oligomer administered at micromolar concentrations was delivered to >80% of cells and inhibited virus titers 10- to 100-fold in a sequence-specific and dose-responsive manner. In addition, targeted viral protein synthesis, plaque diameter, and cytopathic effect were significantly reduced. Inhibition of virus infectivity by peptide-conjugated morpholino was comparable to the antiviral activity of the aminoglycoside hygromycin B used at a concentration fivefold higher than the oligomer. These results suggest that this composition of antisense compound has therapeutic potential for control of coronavirus infection.
* Corresponding author. Mailing address: The Scripps Research Institute, Department of Neuropharmacology, Division of Virology, 10550 North Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-7162. Fax: (858) 784-7369. E-mail:
bneuman{at}scripps.edu.

TSRI paper no. 16375-NP.
Journal of Virology, June 2004, p. 5891-5899, Vol. 78, No. 11
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.11.5891-5899.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Swenson, D. L., Warfield, K. L., Warren, T. K., Lovejoy, C., Hassinger, J. N., Ruthel, G., Blouch, R. E., Moulton, H. M., Weller, D. D., Iversen, P. L., Bavari, S.
(2009). Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection. Antimicrob. Agents Chemother.
53: 2089-2099
[Abstract]
[Full Text]
-
Deas, T. S., Bennett, C. J., Jones, S. A., Tilgner, M., Ren, P., Behr, M. J., Stein, D. A., Iversen, P. L., Kramer, L. D., Bernard, K. A., Shi, P.-Y.
(2007). In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus. Antimicrob. Agents Chemother.
51: 2470-2482
[Abstract]
[Full Text]
-
Burrer, R., Neuman, B. W., Ting, J. P. C., Stein, D. A., Moulton, H. M., Iversen, P. L., Kuhn, P., Buchmeier, M. J.
(2007). Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models. J. Virol.
81: 5637-5648
[Abstract]
[Full Text]
-
Yuan, J., Stein, D. A., Lim, T., Qiu, D., Coughlin, S., Liu, Z., Wang, Y., Blouch, R., Moulton, H. M., Iversen, P. L., Yang, D.
(2006). Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry Site. J. Virol.
80: 11510-11519
[Abstract]
[Full Text]
-
Ge, Q., Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., Stein, D. A.
(2006). Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers. Antimicrob. Agents Chemother.
50: 3724-3733
[Abstract]
[Full Text]
-
Enterlein, S., Warfield, K. L., Swenson, D. L., Stein, D. A., Smith, J. L., Gamble, C. S., Kroeker, A. D., Iversen, P. L., Bavari, S., Muhlberger, E.
(2006). VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice. Antimicrob. Agents Chemother.
50: 984-993
[Abstract]
[Full Text]
-
van den Born, E., Stein, D. A., Iversen, P. L., Snijder, E. J.
(2005). Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture. J. Gen. Virol.
86: 3081-3090
[Abstract]
[Full Text]
-
Neuman, B. W., Stein, D. A., Kroeker, A. D., Churchill, M. J., Kim, A. M., Kuhn, P., Dawson, P., Moulton, H. M., Bestwick, R. K., Iversen, P. L., Buchmeier, M. J.
(2005). Inhibition, Escape, and Attenuated Growth of Severe Acute Respiratory Syndrome Coronavirus Treated with Antisense Morpholino Oligomers. J. Virol.
79: 9665-9676
[Abstract]
[Full Text]
-
Deas, T. S., Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D. A., Moulton, H. M., Iversen, P. L., Kauffman, E. B., Kramer, L. D., Shi, P.-Y.
(2005). Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication. J. Virol.
79: 4599-4609
[Abstract]
[Full Text]
-
Kinney, R. M., Huang, C. Y.-H., Rose, B. C., Kroeker, A. D., Dreher, T. W., Iversen, P. L., Stein, D. A.
(2005). Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers. J. Virol.
79: 5116-5128
[Abstract]
[Full Text]
-
Turner, J. J., Arzumanov, A. A., Gait, M. J.
(2005). Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucleic Acids Res
33: 27-42
[Abstract]
[Full Text]